Call to arrange a consultation
+1 416 777 0888
Search the site
Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.
T-504-19
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
